日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic and Epigenomic ctDNA Profiling in Liquid Biopsies from Heavily Pretreated Patients with DNA Damage Response-Deficient Tumors

对接受过大量预处理的DNA损伤反应缺陷型肿瘤患者的液体活检样本进行基因组和表观基因组ctDNA分析

Silverman, Ian M; Schonhoft, Joseph D; Herzberg, Benjamin; Yablonovitch, Arielle; Lagow, Errin; Fiaux, Patrick C; Safabakhsh, Pegah; Sethuraman, Sunantha; Ulanet, Danielle; Yang, Julia; Kim, Insil; Basciano, Paul; Cecchini, Michael; Lee, Elizabeth; Lheureux, Stephanie; Fontana, Elisa; Carneiro, Benedito A; Reis-Filho, Jorge S; Yap, Timothy A; Zinda, Michael; Rosen, Ezra Y; Rimkunas, Victoria

Detection of Biallelic Loss of DNA Repair Genes in Formalin-Fixed, Paraffin-Embedded Tumor Samples Using a Novel Tumor-Only Sequencing Panel

利用新型肿瘤特异性测序方法检测福尔马林固定、石蜡包埋肿瘤样本中DNA修复基因的双等位基因缺失

Glodzik, Dominik; Selenica, Pier; Rogge, Ryan A; Silverman, Ian M; Mandelker, Diana; Harris, Sam; Zhao, Jianhua; Zinda, Michael; Veloso, Artur; Malani, Nirav; Riaz, Nadeem; Koehler, Maria; Daber, Robert D; Johnson, Verity; Rimkunas, Victoria; Reis-Filho, Jorge S

Guiding ATR and PARP inhibitor combinationswith chemogenomic screens

通过化学基因组学筛选指导 ATR 和 PARP 抑制剂组合

Michal Zimmermann, Cynthia Bernier, Beatrice Kaiser, Sara Fournier, Li Li, Jessica Desjardins, Alexander Skeldon, Victoria Rimkunas, Artur Veloso, Jordan T F Young, Anne Roulston, Michael Zinda

ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications

ATM 种系突变胃食管连接部腺癌:临床描述、分子特征和潜在治疗意义

Tony El Jabbour, Maksym Misyura, Darren Cowzer, Michal Zimmermann, Victoria Rimkunas, Antonio Marra, Fatemeh Derakhshan, Pier Selenica, Megan Parilla, Jeremy S Setton, Ozge Ceyhan-Birsoy, Yelena Kemel, Amanda Catchings, Megha Ranganathan, Geoffrey Y Ku, Yelena Y Janjigian, Michael Zinda, Maria Koehl

Synthetic Lethality in Cancer Therapeutics: The Next Generation

癌症治疗中的合成致死:下一代

Setton, Jeremy; Zinda, Michael; Riaz, Nadeem; Durocher, Daniel; Zimmermann, Michal; Koehler, Maria; Reis-Filho, Jorge S; Powell, Simon N

Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression

乳腺癌细胞中CCL2/CCR2信号蛋白的表达与侵袭性进展相关。

Wei Bin Fang # ,Diana Sofia Acevedo # ,Curtis Smart ,Brandon Zinda ,Nadia Alissa ,Kyle Warren ,Garth Fraga ,Li-Ching Huang ,Yu Shyr ,Wei Li ,Lu Xie ,Vincent Staggs ,Yan Hong ,Fariba Behbod ,Nikki Cheng

CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments

乳腺癌细胞中的CCR2信号通路通过促进CCL2表达和抑制CD154表达,从而促进肿瘤生长和侵袭,进而影响血管生成和免疫微环境。

Gage Brummer # ,Wei Fang # ,Curtis Smart ,Brandon Zinda ,Nadia Alissa ,Cory Berkland ,David Miller ,Nikki Cheng

BRD4 facilitates replication stress-induced DNA damage response

BRD4促进复制应激诱导的DNA损伤反应

Jingwen Zhang ,Austin M Dulak ,Maureen M Hattersley ,Brandon S Willis ,Jenni Nikkilä ,Anderson Wang ,Alan Lau ,Corinne Reimer ,Michael Zinda ,Stephen E Fawell ,Gordon B Mills ,Huawei Chen

Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms

趋化因子信号通过成纤维细胞依赖性机制促进早期乳腺癌存活和侵袭

Gage Brummer #, Diana S Acevedo #, Qingting Hu, Mike Portsche, Wei Bin Fang, Min Yao, Brandon Zinda, Megan Myers, Nehemiah Alvarez, Patrick Fields, Yan Hong, Fariba Behbod, Nikki Cheng

CXCL1 Derived from Mammary Fibroblasts Promotes Progression of Mammary Lesions to Invasive Carcinoma through CXCR2 Dependent Mechanisms

源自乳腺成纤维细胞的CXCL1通过CXCR2依赖性机制促进乳腺病变发展为浸润性癌

Shira Bernard ,Megan Myers ,Wei Bin Fang ,Brandon Zinda ,Curtis Smart ,Diana Lambert ,An Zou ,Fang Fan ,Nikki Cheng